Introduction
============

Functional brain imaging has assumed a leading role in neuropsychiatric research. However, findings reported for mental disorders often vary. Whether this reflects diversity in pathophysiology or heterogeneity of imaging techniques and data analysis procedures is still unknown. Single photon emission computed tomography (SPECT) is one of the techniques of functional imaging that can be used to detect regional cerebral blood flow (rCBF) in the brain of subjects in different states. rCBF is closely related to metabolism and physiology of the brain. The technique of SPECT was first used in psychiatry in the early 1990s ([@b8-ndt-2-43]), when it was found that depressed patients showed reduced uptake in most cortical and subcortical regions examined, most significantly in temporal, inferior frontal, and parietal areas. SPECT was first used in the study of depression in China in 1995 ([@b16-ndt-2-43]), then later in schizophrenia, Alzheimer's disease, and other mental disorders. Since then, many studies have been made using SPECT in mental disorders in China. What are the results of SPECT studies in China? What are the differences between these results in China and those in other countries? Here we review SPECT studies in psychiatry in China.

Method
======

We collected all SPECT papers focused on depression, schizophrenia, Alzheimer's disease, anxiety disorder, and obsessive compulsive disorder published in the Chinese language in China and available in the Chinese Biomedical Bibliographic Database from 1990 to 2004. All publications have been copyrighted and published openly in China. All patients and researchers are Chinese. All overlapping articles were excluded.

Results
=======

We found a total of 31 articles fitting our defined criteria. Three were excluded due to overlap. Six papers were studies on depression ([@b16-ndt-2-43], [@b15-ndt-2-43]; [@b50-ndt-2-43], [@b51-ndt-2-43]; [@b22-ndt-2-43]; [@b6-ndt-2-43]), 9 studied Alzheimer's disease (AD) ([@b21-ndt-2-43]; [@b31-ndt-2-43]; [@b2-ndt-2-43]; [@b3-ndt-2-43]; [@b4-ndt-2-43], 2000; [@b48-ndt-2-43]; [@b47-ndt-2-43]; [@b38-ndt-2-43]), and 13 others studied schizophrenia ([@b19-ndt-2-43]; [@b27-ndt-2-43]; [@b28-ndt-2-43]; [@b29-ndt-2-43]; Li et al 1997; [@b49-ndt-2-43]; [@b24-ndt-2-43]; [@b52-ndt-2-43]; [@b26-ndt-2-43]; [@b25-ndt-2-43]; [@b30-ndt-2-43]; [@b43-ndt-2-43]; [@b44-ndt-2-43]). Only 1 study was found on anxiety disorder ([@b43-ndt-2-43]), 1 on obsessive compulsive disorder (OCD) ([@b26-ndt-2-43]), and 1 on heroin addicts ([@b44-ndt-2-43]).

Depression
----------

As shown in [Table 1](#t1-ndt-2-43){ref-type="table"}, there was only 1 retrospective study, which included just 5 patients ([@b16-ndt-2-43]). Patients with reactive depression showed low rCBF only in the right temporal lobe whereas subjects with endogenous depression displayed low rCBF both in the right temporal lobe and the right frontal-parietal lobe. Five other papers concerned prospective controlled studies with larger samples, from 11 to 39 subjects, using ICD-10, DSM-IV, CCMD-2, and CCMD-2-R criteria.

All 6 studies found lower rCBF in the frontal lobe of patients with depression than in controls: 1 was in the right frontal ([@b16-ndt-2-43]), 2 in the left frontal ([@b15-ndt-2-43]; [@b50-ndt-2-43]), and 3 were bilateral ([@b22-ndt-2-43]; [@b51-ndt-2-43]; [@b6-ndt-2-43]). Four authors found lower rCBF in the temporal lobe also ([@b16-ndt-2-43], [@b15-ndt-2-43]; [@b50-ndt-2-43], [@b51-ndt-2-43]). Five studies found lower rCBF in the parietal lobe, mainly in the right ([@b16-ndt-2-43], [@b15-ndt-2-43]; [@b22-ndt-2-43]; [@b51-ndt-2-43]; [@b6-ndt-2-43]). Four studies showed lower rCBF in the occipital lobe, 1 in the left ([@b16-ndt-2-43]), the other in the right ([@b15-ndt-2-43]), and 2 in both sides in older-age depression ([@b22-ndt-2-43]; [@b6-ndt-2-43]). Three studies also reported lower rCBF in basal ganglia, 2 on both sides ([@b16-ndt-2-43]; [@b22-ndt-2-43]), but 1 only in the right side of old patients ([@b51-ndt-2-43]). Three studies dealt with old patients with depression; the results showed lower rCBF in the right parietal lobe ([@b51-ndt-2-43]; [@b6-ndt-2-43]), and only 1 study showed lower rCBF in the left parietal in the activated state ([@b50-ndt-2-43]). Patients in the studies of [@b22-ndt-2-43] and [@b5-ndt-2-43] were the same. Only [@b15-ndt-2-43] reported lower rCBF in cingulate, and only [@b22-ndt-2-43] in the thalamus. Perfusion asymmetry in temporal, frontal, and occipital lobes was observed in 2 studies, with lower perfusion in the left than in the right. Also perfusion in the thalamus was lower in the right than in the left ([@b15-ndt-2-43]; [@b6-ndt-2-43]). Three studies used patients with first-episode depression ([@b50-ndt-2-43]; [@b22-ndt-2-43]; [@b6-ndt-2-43]).

Alzheimer's disease
-------------------

We found that all of the 8 papers dealing with AD reported lower rCBF in frontal, temporal, and parietal lobes ([Table 2](#t2-ndt-2-43){ref-type="table"}) ([@b21-ndt-2-43]; [@b31-ndt-2-43]; [@b2-ndt-2-43]; [@b3-ndt-2-43]; [@b4-ndt-2-43]; [@b47-ndt-2-43]; [@b38-ndt-2-43]; [@b5-ndt-2-43]). In contrast, 3 of 9 studies did not find that rCBF was significantly lower in the frontal lobe of patients with vascular dementia (VD) ([@b3-ndt-2-43]; [@b4-ndt-2-43]; [@b48-ndt-2-43]).

Three articles showed that rCBF was also lower in the basal ganglia of patients with VD ([@b2-ndt-2-43]; [@b47-ndt-2-43]; [@b38-ndt-2-43]), but [@b48-ndt-2-43] found the same result only in patients with Parkinson's disease (PD), not in the VD group. Three authors found rCBF to be lower in the thalamus of VD patients ([@b2-ndt-2-43]; [@b48-ndt-2-43]; [@b38-ndt-2-43]), and 1 reported lower perfusion of rCBF in the hippocampus of AD patients ([@b38-ndt-2-43]). There were 5 reports of lower rCBF in the occipital lobe ([@b31-ndt-2-43]; [@b2-ndt-2-43]; [@b3-ndt-2-43]; [@b4-ndt-2-43]; [@b47-ndt-2-43]), 4 in patients with VD and 1 in AD. rCBF in frontal, temporal, and parietal lobes in patients with AD was significantly lower than in patients with VD, some bilaterally and others in the right lobes only ([@b3-ndt-2-43]; [@b4-ndt-2-43]; [@b47-ndt-2-43]).

Schizophrenia
-------------

Because 3 of the 13 papers about schizophrenia overlapped with other articles, we have included only 10 papers in [Table 3](#t3-ndt-2-43){ref-type="table"}. Most were controlled studies, with only 2 reports on schizophrenia patients without controls ([@b27-ndt-2-43]; [@b31-ndt-2-43]). We found low rCBF in the frontal lobe of patients with schizophrenia in all 10 papers. Some were in the left frontal, others in the right, and some bilateral. Six studies reported lower rCBF also in the temporal lobe in schizophrenia ([@b27-ndt-2-43]; [@b28-ndt-2-43]; [@b29-ndt-2-43]; [@b24-ndt-2-43], [@b25-ndt-2-43]; [@b30-ndt-2-43]). Three authors found lower rCBF in the parietal lobe ([@b27-ndt-2-43]; [@b52-ndt-2-43]; [@b30-ndt-2-43]). Two reports found lower rCBF also in basal ganglia ([@b29-ndt-2-43]; [@b30-ndt-2-43]), but there were only single reports of lower rCBF in the occipital lobe, thalamus, or cingulate respectively ([@b27-ndt-2-43]; [@b52-ndt-2-43]; [@b30-ndt-2-43]). Two reports measured changes of rCBF before and after antipsychotic treatment; 1 reported that rCBF increased by about 50% along with the positive symptoms but did not identify individual antipsychotics, while the other study detected no significant change after risperidone therapy for 8 weeks ([@b52-ndt-2-43]; [@b30-ndt-2-43]).

We found only 1 paper on OCD, 1 in anxiety disorder, and 1 in heroin addicts ([Table 4](#t4-ndt-2-43){ref-type="table"}). rCBF was low in many brain regions such as frontal, temporal, parietal, occipital, thalamus, basal ganglia, vermis, pons, amygdala, precuneus, putamen, cingulated, and orbital gyrus. More studies are needed in these psychiatric disorders in patients in China.

Discussion
==========

To date, only 6 SPECT studies have been made on depression in China. rCBF was significantly lower in many brain regions, eg, frontal, temporal, parietal, occipital, basal ganglia, cingulate, and thalamus. While all of the studies found rCBF to be low mainly in the frontal, and to be related to depression in the basal state, some researchers found rCBF to be lower in the right but others in the left or even to be bilateral frontal. Most reported that rCBF was also low in temporal, parietal, and occipital lobes during depression. The results of low rCBF in frontal and temporal lobes in China are similar to those in North American and Japanese patients ([@b35-ndt-2-43]; [@b20-ndt-2-43]; [@b36-ndt-2-43]; [@b37-ndt-2-43]). So it seems that the frontal cortex plays an important role in the expression of depression ([@b7-ndt-2-43]). Three reports about old patients with depression in [Table 1](#t1-ndt-2-43){ref-type="table"} showed low rCBF low perfusion in basal ganglia ([@b22-ndt-2-43]; [@b51-ndt-2-43]; [@b6-ndt-2-43]), which agrees with findings in North American patients ([@b13-ndt-2-43]; [@b12-ndt-2-43]). Only 1 paper ([@b15-ndt-2-43]) found that low rCBF in cingulate was correlated with depression in Chinese patients, which supports the original results in North America of [@b8-ndt-2-43].

The first SPECT study in Alzheimer's disease (AD) was reported early in 1990 ([@b9-ndt-2-43]). Many nonChinese reports confirmed that perfusion of rCBF was significantly lower in temporal and parietal lobes of patients with AD ([@b18-ndt-2-43]). Chinese studies in [Table 2](#t2-ndt-2-43){ref-type="table"} showed that the rCBF was significantly lower in frontal, temporal and parietal lobe of patients with AD than that of control subjects. Some researchers found rCBF asymmetry in right and left; [@b2-ndt-2-43] reported that rCBF was lower in left than in right temporal lobe in AD, and lower in left than in right temporal, parietal, and occipital lobes in the VD group. [@b14-ndt-2-43] considered that asymmetry of hypoperfusion in the temporal--parietal lobe was a predictor of cognitive defect to differentiate AD from aging-related cognitive changes in North American patients. [@b3-ndt-2-43] found that rCBF in AD was lower in bilateral frontal and right parietal lobes than in VD, but also reported lower perfusion of rCBF in the right temporal and right occipital in AD than that in VD; left parietal rCBF in AD was also higher than that of the VD group ([@b2-ndt-2-43]).

[@b38-ndt-2-43] found the severity of AD to be associated with low perfusion of rCBF in the hippocampus. Four of 8 papers including VD patients did not show low rCBF in the frontal lobe ([@b21-ndt-2-43]; [@b3-ndt-2-43]; [@b4-ndt-2-43]; [@b47-ndt-2-43]). Some investigators also found lower rCBF in the thalamus and basal ganglia in patients with VD ([@b31-ndt-2-43]; [@b2-ndt-2-43]; [@b47-ndt-2-43]; [@b38-ndt-2-43]), but the results for the occipital lobe were contradictory.

Schizophrenia is a common disorder. According to the 10 papers listed in [Table 3](#t3-ndt-2-43){ref-type="table"}, all researchers found that rCBF perfusion was significantly lower in the frontal lobe of patients with schizophrenia, many of them showing problems also in the left side. Most of the studies ([@b21-ndt-2-43]; [@b3-ndt-2-43]) in [Table 3](#t3-ndt-2-43){ref-type="table"} also showed lower rCBF occurring in the temporal lobe, with some reporting lower rCBF bilaterally and others finding it in the right or left temporal lobe; the results at present are inconsistent. These results are similar to those in nonChinese patients ([@b1-ndt-2-43]; [@b45-ndt-2-43]; [@b46-ndt-2-43]). [@b29-ndt-2-43] found that there was no significant difference between negative and positive symptoms in terms of lower perfusion of rCBF, both types being associated with lower rCBF in the brain, but [@b49-ndt-2-43] and [@b24-ndt-2-43] reported that the negative symptoms of schizophrenia might be related to the perfusion of rCBF in the left frontal lobe. [@b1-ndt-2-43] and [@b40-ndt-2-43] found similar results in nonChinese patients.

After treatment with risperidone, [@b24-ndt-2-43] found that perfusion in the thalamus and superior posterior temporale was decreased significantly, with parallel improvement in positive symptoms, similar to that in nonChinese reports ([@b10-ndt-2-43]; [@b41-ndt-2-43]; [@b34-ndt-2-43]; [@b39-ndt-2-43]).

For late-onset schizophrenia, [@b30-ndt-2-43] found lower rCBF in the left frontal, left parietal, bilateral temporal, bilateral basal ganglia, and right thalamus ([@b30-ndt-2-43]), similar to the nonChinese results of [@b23-ndt-2-43], [@b17-ndt-2-43], and [@b42-ndt-2-43].

There were few studies of other mental disorders in China, with only 1 paper on OCD, one on anxiety disorders, and one on heroin addicts ([Table 4](#t4-ndt-2-43){ref-type="table"}). [@b25-ndt-2-43] found that the results of rCBF were different with different ways of analysis, rCBF being lower in the right anterior temporal, temporo-parietal, and left temporo-occipital lobes of patients with OCD using the regions of interest (ROI) method, but low in bilateral putamen, superior temporal gyrus, precuneus, right orbital gyrus, superior and middle frontal gyrus, left temporo-occipital lobes, superior parietal gyrus, vermis with SPM analysis. [@b43-ndt-2-43] found that rCBFs of brain were generally decreased under stressor stimulation, similar to the findings in nonChinese patients of [@b33-ndt-2-43]. [@b43-ndt-2-43] did not find low perfusion in the cerebellum, but [@b11-ndt-2-43] found the abnormality in nonChinese PTSD patients. [@b44-ndt-2-43] indicted that frontal, temporal, and amygdala rCBF changes were associated with relapsing processes during exposure to heroin-related cues.

According to all the above studies, we found that perfusion of rCBF was abnormal in mental disorders, but the specificity of the abnormality is not consistent. From [Table 5](#t5-ndt-2-43){ref-type="table"}, we know that lower rCBF could be seen mostly in frontal, temporal, and parietal lobes of patients with depression, AD, schizophrenia, and VD. It seems that the abnormality of the frontal lobe is more common in depression and schizophrenia, but temporal lobe abnormality is more common in AD and VD. The perfusion of rCBF in the parietal lobe seems related to aging, because older patients seem to have lower perfusion of rCBF. The abnormality in the occipital lobe and basal ganglia seems to have an association with vascular problems according to the results presented in [Table 5](#t5-ndt-2-43){ref-type="table"}, supporting the hypothesis of vascular depression for old patients. The problem in the thalamus was correlated mainly with VD, and in the cingulate largely with depression and schizophrenia. One paper found AD associated with the hippocampus. There were few reports of anxiety disorders and other mental problems. It seems likely that brain abnormalities in Chinese psychiatric patients are similar to those in nonChinese populations, at least as measured by rCBF changes in SPECT studies. We need multicenter, large-sample, same-diagnosis-criteria, prospective, controlled, collaborative studies across populations to provide more specific information on the pathophysiology in mental disorders.

###### 

A review of SPECT papers on depression in China

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors           Number and age               Course and method                     Diagnostic criteria and tools   rCBF results of patients
  ----------------- ---------------------------- ------------------------------------- ------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b16-ndt-2-43]   5 P (23--60 yr, 40 ± 12)     \< 2 yr first episode\                CCMD-2\                         Low in right temporal, frontal, parietal, and left occipital lobes; bilateral basal ganglia in 3 patients with endogenous depression. Low in right temporal lobe in reactive depression.
                                                 Self-control\                         HAMD (24 items) 22--43          
                                                 ^99m^Tc-ECD\                                                          
                                                 1110 MBq                                                              

  [@b15-ndt-2-43]   11 P (23--60 yr, 43 ± 12)\   7 ± 3 m\                              CCMD-2\                         Low in left inferior frontal, left anterior temporal, and cingulate. Low in right superior, inferior frontal and bilateral parietal, and occipital lobes. Asymmetry in right superior frontal.
                    13 C (20--59 yr, 42 ± 14)    Drug free or stop for 1 wk to 12 m\   HAMD (24 items)\                
                                                 ^99m^Tc-ECD\                          38.9 ± 10.8                     
                                                 925--1225 MBq\                                                        
                                                 ROI                                                                   

  [@b50-ndt-2-43]   27 P (17--51 yr, 33 ± 11)\   3 m--2 yr first episode drug free\    ICD-10\                         Low in left frontal, temporal lobes in baseline and activated. Low in left parietal lobe only in activated.
                    15 C (20--53 yr, 36 ± 12)    ^99m^Tc-ECD\                          WCST\                           
                                                 1110 MBq\                             HAMD (24 items)\                
                                                 ROI                                   31--38                          

  [@b51-ndt-2-43]   39 P (17--55 yr)\            3 m--2 yr first episode drug free\    ICD-10\                         Low in bilateral frontal and temporal lobes both at baseline and activated, but low in parietal lobe only at activated in non-old patients. Low in bilateral frontal, temporal lobes, and right basal ganglia both at baseline and activated in old patients with depression, but right parietal only at activated.
                    17 C (21--50 yr)\            ^99m^Tc-ECD\                          CCMD-2-R\                       
                    18ED (62--76 yr)\            ROI                                   WCST\                           
                    21C (60--72 yr )                                                   HAMD (24items)\                 
                                                                                       24--49                          

  [@b22-ndt-2-43]   22 ED (67 ± 4yr)\            No course, first episode\             ICD-10\                         RAR: Low in bilateral basal ganglia, frontal, and occipital lobes; right parietal lobe and thalamus. Cognitive disorder related to bilateral occipital, left temporal lobe.
                    26 C (68 ± 4yr)              ^99m^Tc-ECD\                          HAMD (24 items)\                
                                                 925--1110 MBq\                        MMSE                            
                                                 ROI\                                                                  
                                                 RAR                                                                   

  [@b6-ndt-2-43]    22 ED (67 ± 4 yr)\           No course, first episode of ED\       DSM-IV\                         Low in right parietal, bilateral frontal and occipital lobes. Perfusion asymmetry in temporal, frontal and occipital lobes lower in left than right but thalamus lower in right than left. Increase in bilateral temporal lobe, basal ganglia, thalamus, and cingulate in patients with depression compared with AD patients.
                    26 C (68 ± 4 yr)\            Drug free\                            HAMD (24-items)\                
                    26 AD (68 ± 7 yr)            ROI\                                  MMSE                            
                                                 RAR                                                                   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** AD, Alzheimer's disease; C, controls; CCMD-2, Chinese Classification of Mental Disorders-2; DSM-IV, Diagnostic and statistical manual of mental disorders, 4th edition; ED, elderly depression; HAMD, Hamilton depression scale; ICD-10, The ICD-10 classification of mental and behavioural disorders, clinical description and diagnostic guideline; MMSE, mini-mental state examination; m, month; P, patients; RAR, radioactive ratios; ROI, regions of interest; wk, week; WCST, Wisconsin card sorting test; yr, years.

###### 

A review of SPECT studies on Alzheimer's disease in China

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors           Number and age                            Course and method                        Diagnostic criteria and tools   rCBF results of patients
  ----------------- ----------------------------------------- ---------------------------------------- ------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b21-ndt-2-43]   AD 9 (53--81 yr, 64 ± **??**)\            No course\                               ICD-10\                         Low in frontal-parietal lobe 3 cases, in temporal- parietal lobe, parietal lobe, and frontal-temporal lobe each 1 case in AD. Results of patients with VD same with CT results; no detailed description.
                    VD 10 (52--70 yr, 59 ± **??**)            ^99m^Tc-ECD                              NINCDS-ADRDA\                   
                                                                                                       VD Hachinski scale \> 7\        
                                                                                                       AD Hachinski scale \< 4\        
                                                                                                       CT scan\                        
                                                                                                       WAIS                            

  [@b31-ndt-2-43]   VD 33 (50--70 yr, 61 ± 6)\                0.5--3 yr\                               DSM-III-R\                      Low in left frontal and temporal lobe related to VIQ in VD, but low in left temporal and right frontal lobe with VIQ in AD. Low in left frontal, and right parietal, thalamus related to FIQ in VD, but low in right parietal and occipital with PIQ in AD.
                    AD 21 (52--76 yr, 60 ± 7)\                VD 1.6 ± 0.6\                            VD Hachinski scale \> 7\        
                    C 24 (51--68 yr, 59 ± 6)                  AD 3.1 ± 0.6\                            AD Hachinski scale \< 4\        
                                                              ^99m^Tc-ECD\                             WAIS\                           
                                                              740--825 MBq\                            WMS\                            
                                                              self-statistic method for radio-number   HRNB                            

  [@b3-ndt-2-43]    AD 36 (71 ± 6 yr)\                        No course\                               DSM-IV\                         Compared with control subjects, low in all lobes except bilateral occipital in AD. Compared with control subjects, low in all parts except right occipital and bilateral frontal in VD. Comparing VD, low in bilateral frontal and right parietal lobe in AD.
                    VD 35 (72 ± 4 yr)\                        ^99m^Tc-ECD\                             CT scan\                        
                    C 37 (70 ± 4 yr)                          925--1110 MBq\                           VD Hachinski scale \> 7         
                                                              ROI                                                                      

  [@b2-ndt-2-43]    AD 17 (51--80 yr, 70 ± 8)\                No course\                               DSM-IV\                         Abnormal rate (%) of AD was 38.2 in frontal, 47.1 in temporal, 52.9 in parietal, and 5.9 in occipital lobes. Lower in left superior and inferior temporal lobe than in right within AD group. Abnormal rate (%) of VD was 50.0 in frontal, 58.3 in temporal, 33.3 in parietal, and 16.7 in occipital lobes, 12.5 in basal ganglia and 8.3 in thalamus. Lower in left superior and inferior temporal, left parietal, and left occipital lobes than in right lobes within VD group. Lower in right inferior temporal and right occipital in AD than in VD, but higher in left parietal in AD than in VD.
                    VD 12 (67--82 yr, 73 ± 5)                 ^99m^Tc-ECD\                             VD Hachinski scale \> 7\        
                                                              925--1110 MBq\                           AD Hachinski scale \< 4\        
                                                              ROI\                                     MMSE\                           
                                                              RAR                                      CT or MRI scan                  

  [@b48-ndt-2-43]   VD 30 (62--89 yr, 75 ± 6)\                VD 2.5 yr\                               DSM-III-R\                      Lower in all lobes except frontal lobe, right occipital and left thalamus in VD than in control. Lower in parietal, temporal, basal ganglia and thalamus in PD than in control. Lower in left temporal lobe than that of right in PD. No difference between VD and PD.
                    PD 31 (61--90 yr, 74 ± 6)\                PD 3yr\                                  NINDS-AIREN\                    
                    C 30 (60--78 yr, 71 ± 4)                  ^99m^Tc-ECD\                             VD Hachinski scale \> 7\        
                                                              925--1110 MBq\                           MMSE\                           
                                                              RAR                                      CT scan\                        
                                                                                                       NPT                             

  [@b4-ndt-2-43]    AD 36 (71 ± 6 yr)\                        No course\                               DSM-IV\                         Results of RAR: Lower in all lobes except bilateral occipital lobe in AD than in control. Lower in all lobes except right occipital and bilateral frontal lobes in VD than in control. Lower in right parietal and bilateral frontal in AD than in VD.
                    VD 35 (72 ± 4 yr)\                        ^99m^Tc-ECD\                             CT scan\                        
                    C 37 (70 ± 4 yr)                          925--1110 MBq\                           VD Hachinski scale \> 7\        
                                                              ROI\                                     MMSE\                           
                                                              RAR                                      NPT                             

  [@b47-ndt-2-43]   AD 15 (59--79yr, 69±6)\                   No course\                               DSM-III-R\                      Lower in AD and VD than in control. Lower in frontal, temporal, and parietal lobe in AD group than in control. Lower in all lobes and basal ganglia in VD group than that of control. Low in temporal and parietal related to MMSE in AD. No report compared AD and VD.
                    VD 24 (43--83yr, 70±9)\                   ^99m^Tc-ECD\                             NINCDS-ADRDA\                   
                    C 15 (50--85yr, 66±9)                     Patlak plot analysis                     MMSE\                           
                                                                                                       Hachinski scale                 

  [@b38-ndt-2-43]   AD 36 (60--84 yr, 71 ± 8)\                7--29 m (16 ± 8)\                        DSM-III-R\                      Lower in AD and VD than in control. Lower in temporal, frontal, parietal and hippocampus in AD than in control. Lower in temporal, parietal, frontal, thalamus and basal ganglia in VD than in control. The severity of AD was related to lower rCBF in hippocampus.
                    VD 32 (60--81 yr, 70 ± 8)\                3--30 m (17 ± 8)\                        NINCDS-ADRDA\                   
                    C 30 (60--83 yr, 70 ± 8)                  ^99m^Tc-ECD\                             MMSE\                           
                                                              925--1110 MBq\                           Hachinski scale\                
                                                              RAR                                      MRI                             

  [@b5-ndt-2-43]    AD 66 (60--65, 9 66--70, 14 \> 70, 43)\   No course\                               DSM-IV\                         Lower in bilateral temporal, frontal, and parietal lobes in AD than in control. No difference between 60--65, 66--70, \> 70 years-old groups.
                    C 73 (60--65, 25 66--70, 23 \> 70, 25)    RAR                                      MMSE\                           
                                                                                                       MRI                             
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** AD, Alzheimer's disease; C, control, CT, computer tomography; DSM-IV, DSM-III, Diagnostic and statistical manual of mental disorders, 4th edition, 3rd edition; FIQ, final IQ; Hachinski, Hachinski ischemic score; HRNB, Halstead-Reitan neuropsychological battery; ICD-10, The ICD-10 classification of mental and behavioural disorders, clinical description and diagnostic guideline; m, month; MMSE, mini-mental state examination; MRI, magnetic resonance imaging; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association; NINDS-AIREN, National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences ; PD, Parkinson's disease, PIQ, practice IQ; RAR, radioactive ratios; ROI, regions of interest; VD, vascular dementia; VIQ, verbal IQ, WAIS, Wechsler's adult intelligence scale; WMS, Wechsler's memory scale; NPT, neuropsychological test; yr, year;

###### 

A review of SPECT studies on schizophrenia in China

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors           Number and age                              Duration and method          Diagnostic criteria and tools                            rCBF results of patients
  ----------------- ------------------------------------------- ---------------------------- -------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b28-ndt-2-43]   32 S\                                       G 1, 0.3--2.9 yr\            ICD-10\                                                  The abnormality of SPECT in group schizophrenia was 93.8% lower in bilateral frontal, left temporal lobes, and right basal ganglia in schizophrenia. Lower in left temporal than in right lobe within schizophrenia group.
                    G1, 14 18--54 yr\                           First time untreated\        CCMD-2\                                                  
                    G2, 18 25--58 yr\                           G 2, 5--18 yr\               CT                                                       
                    21 C 18--58 yr                              Treated\                                                                              
                                                                ^99m^Tc-ECD\                                                                          
                                                                1110 MBq\                                                                             
                                                                Nickel's analysis                                                                     

  [@b27-ndt-2-43]   9 S 31 ± 12 yr                              20 d--17 yr No\              CCMD-2                                                   Low in right temporal in all patients. Low in bilateral temporal and frontal in 6 patients, and right parietal and left occipital in 4 patients.
                                                                ^99m^Tc-ECD\                                                                          
                                                                925--1225 MBq                                                                         

  [@b19-ndt-2-43]   22 S 18--42 yr\                             6 m--21 yr\                  CCMD-2                                                   4 patients with abnormal rCBF at baseline. Left frontal activation deficit.
                    10 C 18--33 yr                              ROI\                                                                                  
                                                                ^99m^Tc-ECD\                                                                          
                                                                740 MBq                                                                               

  [@b29-ndt-2-43]   25 S1 (negative group) 16--54 yr\           0.8--20 yr (9 ± 6 yr)\       CCMD-2                                                   Lower in frontal, temporal and basal ganglia in both groups than in control, but no significant differences within patients. No abnormalities in control group.
                    25 S2 (non-negative group) 18--58 yr 21 C   0.3--20 yr (5 ± 5 yr)\                                                                
                                                                Nickel's analysis\                                                                    
                                                                ^99m^Tc-ECD\                                                                          
                                                                1110 MBq                                                                              

  [@b31-ndt-2-43]   12 S 18--45 yr                              No course recorded\          DSM-IV\                                                  Lower in left frontal than that of right lobe, no increase in left frontal lobe after WCST. Negative symptoms might be related to left frontal lobe.
                                                                Drugs free within a month\   CCMD-2-R\                                                
                                                                Pan's analysis\              WCST\                                                    
                                                                ^99m^Tc-ECD\                 Andreasen's negative schizophrenia diagnostic criteria   
                                                                12 mic--18 mic                                                                        

  [@b49-ndt-2-43]   22 S\                                       0.5--9.9 yr\                 CCMD-2\                                                  Low in left frontal in both negative groups. Lower in right superior frontal in group of high score of SANS.
                    high negative group,\                       ^99m^Tc-ECD\                 SANS\                                                    
                    9, 31 ± 9 yr\                               740 MBq\                     BPRS\                                                    
                    low negative group,\                        ROI analysis                 WCST                                                     
                    13, 29 ± 7 yr\                                                                                                                    
                    10 C 26 ± 5 yr                                                                                                                    

  [@b24-ndt-2-43]   24 S 18--50 yr\                             10.8 ± 14.3 m\               ICD-10\                                                  Before treatment with risperidone, rCBF was higher in bilateral inferior posterior temporal lobe at baseline, but lower in left mid-lateral frontal after cognitive activation. After treatment rCBF significantly lower in right lateral temporal, bilateral superior posterior temporal lobe. After cognitive activation rCBF increase in bilateral inferior medial frontal, left inferior lateral frontal, left superior fronto-temporal, and left superior lateral frontal.
                    26 C 18--50 yr                              untreated\                   SANS\                                                    
                                                                ^99m^Tc-ECD\                 SAPS\                                                    
                                                                925--1110 MBq\               PANSS\                                                   
                                                                ROI analysis                 WCST                                                     

  [@b52-ndt-2-43]   22 S Age 18--55 yr\                         1--3 yr\                     CCMD-2-R                                                 Abnormality in 82% (18/22). Lower in right frontal, parietal, temporal, and cingulate in schizophrenia group than in control. 8 patents tested before and after treatment, 100% abnormal before treatment, and 50% still abnormal after treatment. Significant changes in right frontal and temporal lobes.
                    10 C Age 21--47 yr                          ^99m^Tc-ECD\                                                                          
                                                                925--1110 MBq\                                                                        
                                                                SPM\                                                                                  
                                                                ROI                                                                                   

  [@b25-ndt-2-43]   32 S 18--50 yr\                             12.3 ± 20.0 m\               ICD-10\                                                  The baseline ratio of rCBF was higher in bilateral inferior posterior temporal lobe but lower in right frontal-temporal and left mid-medial frontal.
                    26 C 18--50 yr                              untreated\                   Paranoid type\                                           
                                                                ^99m^Tc-ECD\                 WCST                                                     
                                                                925--1110 MBq\                                                                        
                                                                ROI                                                                                   

  [@b25-ndt-2-43]   21 S Age 52--76 yr\                         6--54 m\                     DSM-III-R\                                               Lower in left frontal, parietal, bilateral inferior temporal lobes, basal ganglia, right thalamus. Lower in left frontal than in right. RARS was not significantly changed in all regions after treatment with risperidone for 8 weeks in 11 patients.
                    (61 ± 7 yr)\                                First episode late onset\    CT\                                                      
                    20 C Age 54--75 yr\                         ^99m^Tc-ECD\                 MRI\                                                     
                    (65 ± 5 yr)                                 925--1110 MBq\               MMSE\                                                    
                                                                ROI\                         WCST                                                     
                                                                RAR                                                                                   
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** BPRS, brief psychiatric rating scale; CCMD-2-R, Chinese Classification of Mental Disorders-2-revision; CT, computerised tomography; C, controls; d, days; DSM-IV, Diagnostic and statistical manual of mental disorders fourth edition; G, group; ICD-10, the ICD-10 classification of mental and behavioural disorders, clinical description and diagnostic guideline; m, months; MMSE, MMSE, mini-mental state examination; MRI, magnetic resonance imaging; PANSS, positive and negative syndrome scale; RAR, radioactive ratios; ROI, regions of interest; SANS, scale for assessment of negative symptoms; SAPS, scale for assessment of positive symptoms; S, schizophrenia; SPM, statistical parametric mapping; WCST, Wisconsin card sorting test; yr, years.

###### 

A review of SPECT studies on other mental disorders in China

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors           Number and age         Duration and method   Diagnostic criteria and tools                  rCBF results of patients
  ----------------- ---------------------- --------------------- ---------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b26-ndt-2-43]   14 OCD (30 ± 12 yr)\   No record\            ICD-10 Yale Brown obsessive-compulsive scale   Low in bilateral putamen, superior temporal lobe, gyrus, precuneus, right orbital gyrus, superior and middle frontal gyrus, left temporal-occipital lobe, superior parietal gyrus, and vermis with SPM analysis. Low in right anterior temporal lobe, temporal-parietal lobe, and left temporal-occipital lobe with ROI analysis.
                    23 C no record         ^99m^Tc-ECD\                                                         
                                           740 MBq\                                                             
                                           SPM and ROI                                                          

  [@b43-ndt-2-43]   20 ANX 25--63 yr\      No record\            CCMD-2-R\                                      Lower in frontal, temporal lobes, thalamus and basal ganglia at baseline state. Lower in pons, frontal, temporal, parietal, occipital lobes, thalamus, and basal ganglia during stress condition. Significant increase in all regions of patients after modified stressor stimulation.
                    20 C 22--60 yr         ^99m^Tc-ECD\          HAMA\                                          
                                           925--1110 MBq\        HAMD                                           
                                           ROI                                                                  

  [@b44-ndt-2-43]   25 ADI 20--45 yr       No record\            DSM-IV                                         Increase in frontal, temporal lobes, and amygdala during exposure to heroin-related cues.
                                           ^99m^Tc-ECD\                                                         
                                           925--1110 MBq\                                                       
                                           ROI and RAR                                                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** ADI, heroin addict; ANX, anxiety disorder; CCMD-2-R, Chinese Classification of Mental Disorders-2-revision; DSM-IV, Diagnostic and statistical manual of mental disorders fourth edition; HAMA, Hamilton anxiety scale; HAMD, Hamilton depression scale; ICD-10, The ICD-10 classification of mental and behavioural disorders, clinical description and diagnostic guideline; OCD, obsessive compulsive disorder; RAR, radioactive ratios; ROI, regions of interest; yr, years.

###### 

A comparison of rCBF distribution of SPECT in depression, AD, VD, and schizophrenia

  -------------------------------------------------------------------------------------------------------------
  Items           Depression                   AD                           VD     Schizophrenia
  --------------- ---------------------------- ---------------------------- ------ ----------------------------
  Frontal         ++++\                        ++++\                        ++     ++++\
                  Asymmetry in right or left   Asymmetry in right or left          Asymmetry in right or left

  Temporal        +++                          ++++                         ++++   +++

  Parietal        +++ old patient              ++++                         ++++   ++

  Occipital       +++                          \+                           +++    \+

  Thalamus        \+                           ?                            +++    \+

  Basal ganglia   ++ old patient               ?                            +++    \+

  Cingulate       \+                           ?                            ?      \+

  Hippocampus     ?                            \+                           ?      ?
  -------------------------------------------------------------------------------------------------------------

**Abbreviations:** AD, Alzheimer's disease; VD, vascular dementia.
